OPK NASDAQ
OPKO Health, Inc.
1W: -4.9%
1M: -7.7%
3M: +4.0%
YTD: +22.8%
1Y: +0.7%
3Y: +0.0%
5Y: -58.4%
$1.56
-0.01 (-0.64%)
Weekly Expected Move ±5.4%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (100)
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?
Bank of New York Mellon Corp Takes Position in OPKO Health, Inc. $OPK
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?
OPKO Health (NASDAQ:OPK) Trading Up 8.2% - Here's Why - MarketBeat
$OPK stock is up 8% today. Here's what we see in our data. - Quiver Quantitative
Connor Clark & Lunn Investment Management Ltd. Invests $618,000 in OPKO Health, Inc. $OPK
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
Opko Health Stock Price Forecast. Should You Buy OPK? - StockInvest.us
Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report?
Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report?
3 Penny Stocks With At Least $70M Market Cap - simplywall.st
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - Zacks Investment Research
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
SA Asks: What are the most promising oncology companies right now?
COCP: $5 Million Private Placement with OPKO Health
OPKO Health (OPK) Stock Looks Stretched On Fresh Royalty Backed Financing - simplywall.st
OPK Raises $125 Million Against Royalties: What Investors Should Know
OPK Raises $125 Million Against Royalties: What Investors Should Know
Is OPK Worth Buying as Valuation Meets Improving Business Trends?
Is OPK Worth Buying as Valuation Meets Improving Business Trends?
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?
OPKO Health Secures $125 Million Financing Against Mazdutide Royalties
OPKO Health Secures $125 Million Financing Against Mazdutide Royalties
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know
OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know
OPKO Health: Mazdutide And MDX-2201 Could Change Everything (NASDAQ:OPK) - Seeking Alpha
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
OPKO Health: A Hold As Progress Continues (NASDAQ:OPK) - Seeking Alpha
OPKO Health gives back 17% after sharp post-earnings surge
OPKO Health (OPK) Is Up 36.0% After Narrower Q2 Loss And New 2026 Guidance Has The Bull Case Changed?
Why Opko Health Stock Surged by 33% on Tuesday
Why Opko Health Stock Surged by 33% on Tuesday
OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates
OPKO Health Stock Up as Q2 Earnings & Revenues Beat Estimates
Biggest stock movers Tuesday: BA, UPS, KO, and more
OPKO Health, Inc. Q2 2026 Earnings Call Summary
OPKO Health (OPK) Stock Jumps As Losses Shrink And Pipeline Progress Builds - simplywall.st
OPKO Health Inc (OPK) Q2 2026 Earnings Call Highlights: Strong Pharmaceutical Growth and ...
Opko outlines $560M-$585M 2026 revenue guidance while planning MDX3001 clinical start by end of 2026 or early 2027
OPKO Health Q2 Earnings Call Highlights
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics
OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates
OPKO Health (OPK) Reports Q2 Loss, Tops Revenue Estimates
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
OPKO Health Q2 2026 Earnings Preview
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
OPKO Health Sets July 27 Webcast for Results and Guidance - stocktitan.net
IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?
OPK - Finviz
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
Here's Why You Should Retain OPK Stock in Your Portfolio for Now - Yahoo Finance
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y
This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
OPKO Health Q1 2026 Earnings Call: Complete Transcript
Opko outlines Q2 2026 revenue of $127M-$132M as ModeX advances 5 clinical programs
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
OPKO Health GAAP EPS of -$0.07 in-line, revenue of $124.2M misses by $6.57M
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
Here are the major earnings after the close Tuesday
Earnings Scheduled For April 28, 2026
Earnings week ahead: MSFT, AAPL, GOOG, AMZN, META, XOM, CVX, KO, V, SBUX, F, GM, and more
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
Here's Why You Should Hold OPK Stock in Your Portfolio for Now
Here's Why You Should Hold OPK Stock in Your Portfolio for Now - tradingview.com
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit
OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript
Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics
OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Earnings week ahead: NVDA, CRM, HD, BIDU, LOW, DELL, SNOW, AMC, ZM, and more
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
Reviewing OPKO Health (NASDAQ:OPK) and Coloplast A/S (OTCMKTS:CLPBY)
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
OPKO Health: Deeply Mispriced Ahead Of Major Catalysts
OPKO Health (NASDAQ:OPK) Shares Cross Below Fifty Day Moving Average – Here’s Why
OPKO Health (NASDAQ:OPK) & Positron (OTCMKTS:POSC) Head-To-Head Review
OPKO Health, Inc. (OPK) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
OPKO Health (OPK) Stock Forecast and Price Target 2026 $OPK - MarketBeat
OPK Stock Price and Chart — NASDAQ:OPK - tradingview.com
OPKO Health (OPK) Stock Price, News & Analysis $OPK - MarketBeat
OPKO Health Announces Move to NASDAQ Stock Market - OPKO Health, Inc.